Archive for November 2021
Long-COVID and Epstein-Barr Virus reactivation
Key Points: The prevalence of persistent symptoms after the resolution of acute illness in COVID-19 is approximately 30%. A variety of clinical manifestations have been associated with EBV reactivation, many of which have similarities with symptoms of long-COVID. A recent retrospective study of patients with long-COVID found that 67.7% were positive for EBV reactivation compared…
Read MoreWithania and the evidence of it’s neuroprotective effects
Key Points: There is a growing interest in herbal therapies for mental health and neurological disorders, which are significant global public health issues. A growing body of research demonstrates beneficial effects of withania and its biological constituents in a wide range of mood and neurological disorders. Withania’s neuroprotective action is largely believed to be due…
Read More